Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT in moderate to severe facial acne vulgaris
NCT00706433Phase 2Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- Mar 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid in acne vulgaris, sponsored by DUSA Pharmaceuticals. Started Mar 2007; status: completed.
02
Drugs
aminolevulinic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00706433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706433.